Beijing News recently, a news about super fungi brushed the screen on the Internet. Beijing CDC today issued an official science popularization, saying that healthy people are usually not infected with candida, which poses a low health threat to the general public.
According to the city CDC, the so-called superfungus, named Candida albicans, is a fungus that can cause serious infections in hospitalized cases. Data show that: Candida auricularis has only been found in recent years, and was first found in Japan in 2009; by retrospective detection of stored Candida auricularis, the earliest one appeared in Korea in 1996.
According to statistics, there are currently reports of Candida ear infections in all continents around the world. As of February 28, 2019, 587 confirmed cases were reported in the United States. A small number of cases have been reported in China.
Because healthy people are usually not infected with candida, the health threat of Candida is low for the general public, and the public need not panic, nor need to take special preventive measures.
Question 1: Who is susceptible to Candida ear infection?
Candida infection mainly affects hospitalized cases. High-risk groups are patients with severe chronic underlying diseases or immunosuppression (e.g. diabetes mellitus, chronic nephropathy, HIV infection, tumors), neonates, patients with intubation or indwelling catheters, surgical patients and patients with systemic use of broad-spectrum antibiotics or antifungal drugs can also be infected. Healthy people are usually not infected with candida.
Interpretation 2: What are the hazards?
Candida auricularis can cause both symptomatic infections and asymptomatic carriers in the body.
Symptoms caused by Candida auris depend on the location of infection, including bloodstream infection, wound infection and ear infection, among which bloodstream infection is the most serious, with a mortality rate of 30-40%.
Interpretation 3: What are the main treatment methods at present?
At present, the fungus is mainly resistant to fluconazole, but there are differences in resistance to other antifungal drugs among different strains. At present, there are three main antifungal drug-resistant strains.
Most cases of ear Candida infection can be treated with echinococcin antifungal drugs. For multi-drug resistant cases of ear Candida infection, a combination of high-dose antifungal drugs can be used.
Source: Yang Yi_NBJ10647, Responsible Editor of Beijing Newspaper